Market Tracker

04/28 5:16pm ET

Exelixis Inc (NASDAQ:EXEL)

22.40
Delayed Data
As of Apr 28
 +0.16 / +0.72%
Today’s Change
4.25
Today|||52-Week Range
23.49
+50.23%
Year-to-Date

Today’s Trading

Previous close22.24
Today’s open22.30
Day’s range22.10 - 22.51
Volume2,468,510
Average volume (3 months)4,665,036
Market cap$6.5B
Dividend yield--
Data as of 4:14pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+65.43%
Earnings growth (this year)+116.38%
Earnings growth (next 5 years)+46.00%
Revenue growth (last year)+415.05%
P/E ratioNM
Price/Sales19.51
Price/Book72.71

Competitors

 Today’s
change
Today’s
% change
ICLRICON PLC+1.32+1.59%
CRLCharles River Labora...+0.08+0.09%
PRAHPRA Health Sciences ...+0.09+0.14%
PRXLPAREXEL Internationa...+0.46+0.73%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$191.5M
Annual profit (last year)-$70.2M
Net profit margin-36.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts